-
$208 Billion
6.53% of portfolio
-
Q2 2023
Added 7.29%
-
$143 Billion
4.48% of portfolio
-
Q2 2024
Added 3.68%
-
$130 Billion
4.07% of portfolio
-
Q2 2024
Added 3.68%
-
$110 Billion
3.45% of portfolio
-
Q1 2024
Added 41.82%
$11B
$104 Billion
3.28% of portfolio
759,009
Q2 2024
Added 3.94%
-
$104 Billion
3.28% of portfolio
-
Q2 2024
Added 192.82%
$2.45B
$99.8 Billion
3.13% of portfolio
2,560,573
Q2 2024
Added 95.76%
-
$94.1 Billion
2.95% of portfolio
-
Q2 2024
Added 29.82%
-
$90.8 Billion
2.85% of portfolio
-
Q2 2024
Added 12.36%
Ironwood Pharmaceuticals Inc
-
$84.6 Billion
2.66% of portfolio
-
Q2 2024
Added 70.16%
-
$81.2 Billion
2.55% of portfolio
-
Q2 2024
New
$2.34B
$81.1 Billion
2.54% of portfolio
2,807,968
Q2 2024
Added 13.37%
-
$74.4 Billion
2.33% of portfolio
-
Q2 2024
Added 3.03%
$8.16B
$74 Billion
2.32% of portfolio
1,669,720
Q2 2024
Added 34.24%
-
$73.8 Billion
2.31% of portfolio
-
Q2 2024
Added 13.08%
$30B
$71.8 Billion
2.25% of portfolio
166,924
Q2 2024
Reduced 24.06%
$19.9B
$66.4 Billion
2.08% of portfolio
275,207
Q2 2024
Added 62.6%
$1.09B
$64.6 Billion
2.03% of portfolio
9,024,037
Q2 2024
Added 24.95%
$6.77B
$61 Billion
1.91% of portfolio
808,303
Q2 2024
Reduced 33.35%
-
$59.1 Billion
1.85% of portfolio
-
Q2 2024
Added 388.26%
$4.86B
$58.7 Billion
1.84% of portfolio
1,106,905
Q2 2024
Added 55.22%
$6.2B
$58.8 Billion
1.84% of portfolio
496,576
Q2 2024
Added 10.18%
$2.23B
$56.7 Billion
1.78% of portfolio
526,357
Q2 2024
Added 8.92%
-
$56.6 Billion
1.77% of portfolio
-
Q2 2024
Added 79.49%
-
$55.5 Billion
1.74% of portfolio
-
Q2 2024
Reduced 15.0%
-
$52.3 Billion
1.64% of portfolio
-
Q2 2024
Reduced 2.53%
$6.08B
$50.8 Billion
1.59% of portfolio
379,443
Q2 2024
Added 273.86%
-
$48.8 Billion
1.53% of portfolio
-
Q1 2023
Added 10.87%
$12B
$48.2 Billion
1.51% of portfolio
1,141,678
Q2 2024
New
$1.5B
$44.9 Billion
1.41% of portfolio
982,209
Q2 2024
Added 33.2%
$174B
$44.7 Billion
1.4% of portfolio
100,500
Q1 2024
New
$1.02B
$41.8 Billion
1.31% of portfolio
3,035,904
Q2 2024
Added 39.67%
Avadel Pharmaceuticals PLC
-
$40.8 Billion
1.28% of portfolio
-
Q2 2024
New
$8.26B
$40.8 Billion
1.28% of portfolio
323,509
Q2 2024
Added 126.49%
$242B
$39 Billion
1.22% of portfolio
70,449
Q2 2024
Added 49.42%
Kiniksa Pharmaceuticals Intl
-
$38.4 Billion
1.21% of portfolio
-
Q2 2024
New
$7.36B
$38.3 Billion
1.2% of portfolio
212,594
Q2 2024
Reduced 28.15%
$621M
$31.9 Billion
1.0% of portfolio
1,107,770
Q4 2023
Added 4.73%
$630M
$28.9 Billion
0.91% of portfolio
4,438,232
Q2 2024
Added 27.18%
$5B
$28.6 Billion
0.9% of portfolio
189,960
Q2 2024
Reduced 69.09%
$513M
$28.4 Billion
0.89% of portfolio
4,150,109
Q2 2024
Added 23.31%
$1.37B
$27 Billion
0.85% of portfolio
797,268
Q2 2024
New
$1.33B
$25.4 Billion
0.8% of portfolio
1,084,400
Q2 2024
New
$3.17B
$23.5 Billion
0.74% of portfolio
611,800
Q2 2024
New
$583M
$22.9 Billion
0.72% of portfolio
2,194,900
Q2 2024
New
-
$22.2 Billion
0.7% of portfolio
-
Q2 2024
Added 4.55%
$4.67B
$19.7 Billion
0.62% of portfolio
107,179
Q2 2024
Reduced 39.48%
$851M
$19.6 Billion
0.61% of portfolio
3,006,799
Q2 2024
Reduced 19.69%
$197M
$14.3 Billion
0.45% of portfolio
1,698,768
Q2 2024
Reduced 4.37%
$296M
$13.9 Billion
0.44% of portfolio
8,294,950
Q2 2024
New